Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Technology Sector · Saratoga Advantage

SHPAX Expense Ratio & Fees

Ticker SHPAX · · Holdings as of May 31, 2026

Expense ratio
3%$300/yr per $10k
5-yr return
+3.1%annualized
1-yr return
−5.5%as of Dec 2024
Net assets
$10.5Mall share classes
Holdings
29

Bottom line

What is SHPAX's expense ratio?

SHPAX's expense ratio is 3%, or about $300 a year on every $10,000 invested. That is more expensive than 99% of technology sector funds we track (median 0.75%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.

Updated Dec 29, 2025

SHPAX fee table

Net expense ratio3%
Gross expense ratio3%
Management fee1.25%
Other expenses1.35%
Max front-end sales load5.75%
Max deferred sales charge0%
Redemption fee0%

Source: Fund prospectus fee table, filed Dec 29, 2025

What SHPAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
SHPAX$861$1,449$2,061$3,702

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 3% expense ratio costs roughly $140,100 in lost growth, versus about $42,500 for the median technology sector fund (0.75%).

Cheapest way to own Health & Biotechnology Portfolio

All share classes
TickerClassExpense ratioFront load
SBHIXHealth & Biotechnology Portfolio Class I2.6%0%
SHPAXHealth & Biotechnology Portfolio Class A3%5.75%
SHPCXHealth & Biotechnology Porfolio Class C3.6%0%